Clinical Trials Sponsored by Johnson & Johnson

Total 5112 results

Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry Skin

Skin Care | Skin | Skin Cream

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments. (Microbiome)

Microbiome

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Withdrawn

A Clinical Trial to Test the Effect of an Experimental Mouth Rinse on Gum Disease

Gingivitis
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris

Acne Vulgaris

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Terminated

Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin

Eczema

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Atopic Dermatitis (AD)

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain

Orthodontic Pain

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study to Assess Safety and Improvement in Skin Barrier After Using 2 Facial Sunscreens in Adults With Sensitive Skin

Healthy

Brazil
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and Children

Dermatitis, Atopic

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Two-Week Study of an Anticavity Low pH Mouthwash

Healthy

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study of Experimental Mouthwashes

Gingivitis | Plaque

Canada
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study of Virtually Supervised Mouthwash and Interdental Brushes

Healthy

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Two-Week Study of Clinical Safety and Saliva Flow Quantification

Healthy

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Twelve Week Study of Experimental Mouth Rinses

Gingivitis | Plaque

Canada
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study of Virtually Supervised Mouth Rinses and Flossing

Healthy

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study of 3 Investigational Products on the Microbiome and Scalp Attributes in Children With Curly Hair

Healthy

Brazil
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants

Dermatitis, Atopic | Rosacea | Acne Vulgaris | Sensitive Skin

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study to Assess Wound Healing Efficacies of Different Clean, Treat, and Protect Wound Care Regimens Compared to Standard of Care and Untreated

Wound Healing

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Withdrawn

A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.

Atopic Dermatitis
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Pediatric Microbiome Study With Children Now Approximately 8-10 Years Old.

Healthy Volunteers

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne

Acne Vulgaris

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema

Atopic Dermatitis

United States
Seoul National University Hospital
Johnson & Johnson

Recruiting

Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION) (SOLUTION)

Cervical Cancer | Cervical Cancer Stage IB1 | Minimally Invasive Surgery

Korea, Republic of
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain

Urologic Diseases | Urinary Bladder Diseases | Cystitis | Cystitis, Interstitial

United States, Canada
Ottawa Hospital Research Institute
Johnson & Johnson

Completed

A Clinical Trial of a Metal on Poly Component Versus CORAIL Stem: A Bone Mineral Density Study

Total Hip Arthroplasty

Canada
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis

Pain | Osteoarthritis | Joint Pain | Arthralgia | Osteoarthritis, Knee

United States, Canada
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

Pain | Osteoarthritis | Joint Pain | Arthralgia | Osteoarthritis, Knee | Osteoarthritis, Hip

United States, Poland, Canada, Korea, Republic of
Korea University Guro Hospital
Johnson & Johnson

Completed

Does the Merged 3D Imaging Improve Contact Force and Long Term Procedure Outcome in Atrial Fibrillation? (MICRO-AF)

Atrial Fibrillation

Korea, Republic of
Merck Sharp & Dohme LLC
Johnson & Johnson

Completed

Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) (GO-AHEAD)

Spondylitis, Ankylosing
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers

Healthy

United States
DePuy International
Johnson and Johnson Medical

Completed

Study to Assess the Stability, Efficacy and Safety of the Silent™ Hip Prosthesis in Primary Total Hip Replacement

Osteoarthritis

Australia, Germany
Johnson & Johnson Pharmaceutical Research & Development...

Withdrawn

A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives

Nervous System Malformations | Neural Tube Defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin (JNJ-28431754) in Healthy Indian Volunteers

Healthy

India
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy

Diabetic Neuropathy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults

Allergic Rhinitis

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Nutritional and Metabolic Diseases

United Kingdom, Germany, Belgium, Poland, India, Finland, Sweden, Netherlands, Russian Federation, Norway, Denmark
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Schizophrenia

United States, Taiwan, India
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia

Schizophrenia

Poland, United States, Belgium, Taiwan, Spain, Malaysia, Korea, Republic of, Thailand, Slovakia, Croatia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

United States, Poland, Germany, Mexico, Brazil, Czech Republic, Argentina
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

Malabsorption Syndromes | Cystic Fibrosis | Steatorrhea | Exocrine Pancreatic Insufficiency

United States, Canada
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

Autistic Disorder | Autism

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

Schizophrenia

United States, Colombia, Ukraine, Argentina, Czech Republic, Slovakia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease

Anemia

United States, Puerto Rico
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic and Bioavailability Study of 28431754 (Canagliflozin) in Healthy Male Volunteers

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis

Atopic Dermatitis

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Compare the Dose-proportionality of Tapentadol (CG5503) in Healthy Japanese and Korean Male Volunteers

Healthy Volunteer

Clinical Trials Sponsored by Johnson & Johnson

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations